Literature DB >> 31945855

Clinical and Functional Imaging Changes Induced from Vision Therapy in Patients with Convergence Insufficiency.

Tara L Alvarez, Mitchell Scheiman, Elio M Santos, Cristian Morales, Chang Yaramothu, John Vito d'Antonio-Bertagnolli, Suril Gohel, Bharat B Biswal, Xiaobo Li.   

Abstract

Office-Based Vergence/Accommodative Therapy (OBVAT) is an effective treatment for convergence insufficiency (CI) and remediates symptoms in about 75% of patients. Hence, the study of CI patients can serve as a systems-level model to understand the neural mechanisms evoked from rehabilitation. Symptomatic young adult CI patients (N=25) participated in 12 hours of OBVAT and were compared to 25 binocularly normal controls (BNC) using unpaired t-tests. CI patients have significantly lower near point of convergence and positive fusional vergence and were more symptomatic compared to BNC (p<; 0.0001). Using paired t-tests, significant differences (p<; 0.0001) were observed between CI patients' baseline and post-OBVAT measurements where the near point of convergence decreased, positive fusional vergence increased, and the results from the Convergence Insufficiency Symptom Survey (CISS) decreased. Using paired t-tests, the mean beta weights of the functional activity significantly increased for the frontal eye fields (p<; 0.01) and the oculomotor vermis (p<; 0.05) for CI patients post-OBVAT compared to baseline measurements. These data demonstrate that OBVAT increases functional activity within the brain and improves clinical function and visual symptoms in CI patients.

Entities:  

Year:  2019        PMID: 31945855     DOI: 10.1109/EMBC.2019.8857163

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  2 in total

1.  Dynamics of the Disparity Vergence Fusion Sustain Component.

Authors:  John L Semmlow; Chang Yaramothu; Tara L Alvarez
Journal:  J Eye Mov Res       Date:  2019-12-04       Impact factor: 0.957

2.  Reflexive Fusional Vergence and Its Plasticity Are Impaired in Convergence Insufficiency.

Authors:  Ian M Erkelens; William R Bobier
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.